ADVERTISEMENT
Drugmakers With Exposure To Essential Medicines May Record Best Growth In Years
The impact of price hike on essential drugs will be seen from second quarter onwards, say analysts.
29 Sep 2022, 07:59 AM IST
After years of moderate margins due to limited price hikes, drugmakers with heavy exposure to essential medicines are expected to register better growth.The government approved a 10.8% hike in the price of essential drugs regulated under the Drug Price Control Order, 2013, in line with the Wholesale Price Index effective from April 1. However, the actual impact on the numbers was seen from June 1 due to channel inventory. As a result...
I’m already a Subscriber Sign In
To continue reading this story
Subscribe to unlock & enjoy all Members-only benefits
Choose a plan
Renews automatically. Cancel anytime.
As a Subscriber you get
Access to
Stories
Curated
Newsletters
20,000+
Research Reports
Priority Pass
to Special Events
Ad-Lite
Experience
Members-Only
Rewards
NDTV Profit
Exclusive Stories
Full Access to
NDTV Profit App
Access to
Stories
20,000+
Research Reports
Ad-Lite
Experience
NDTV Profit
Exclusive Stories
Curated
Newsletters
Priority Pass
to Special Events
Members-Only
Rewards
Full Access to
NDTV Profit App
Still Not convinced ? Know More
Get live Stock market updates, Business news, Today’s latest news, Trending stories, and Videos on NDTV Profit.
ADVERTISEMENT